Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 24 Oct 2022 for ChemoCentryx, Inc.. Read the official filing
Filing timeline
BuySaleMarkus J. Cappel
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Markus J. Cappel: trading record in brief
This profile gathers the share dealings of Markus J. Cappel in ChemoCentryx, Inc. Over a trading history stretching from 1 January 2022 to 20 October 2022, the count stands at 3 filings.
No open-market purchase appears, only 1 sale worth €371k. Besides market trades, the filings include 1 option exercise.
The newest entry dates from 24 October 2022: a transaction, in ChemoCentryx, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Markus J. Cappel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
87,658 sharesCommon StockSEC:0000899243-22-034071:0
7,564 shares@ US$50.22100.0% of flowCommon StockSEC:0001209191-22-044889:0
6,667 shares0Common StockSEC:0001209191-22-001330:0
3 of 3 declarations
